Gutscheinbedingungen

**Gültig vom 20.07.2026 bis 22.07.2026 | Gültig für nicht preisgebundene fremdsprachige Bücher | Einzelne Artikel können ausgeschlossen sein | Nicht kombinierbar mit anderen Gutscheinen oder Preisaktionen | Nur einmal pro Einkauf einlösbar | Gutschein wird auf max. 500€ Bestellwert angerechnet | Keine Barauszahlung | Nicht gültig für Versandkosten und Services

  • Produktbild: Cancer Vaccination and Challenges
  • Produktbild: Cancer Vaccination and Challenges

Cancer Vaccination and Challenges Volume 1: Strategies for Therapeutic Cancer Vaccine Development

322,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.11.2024

Abbildungen

farbige, schwarzweisse Abbildungen

Herausgeber

Rishabha Malviya + weitere

Verlag

Taylor and Francis

Seitenzahl

398

Maße (L/B/H)

24/16,1/2,7 cm

Gewicht

930 g

Sprache

Englisch

ISBN

978-1-77491-674-2

Beschreibung

Portrait

Rishabha Malviya, PhD, has 11 years of research experience and is presently working as Associate Professor of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. He has authored over 150 research and review papers and book chapters and edited 13 books to date. He has been included in the World’s Top 2% Scientists list by Elsevier BV and Stanford University. He is a reviewer, editor, and editorial board member of more than 50 national and international journals.

Bhupendra Prajapati, PhD, is a Professor of Pharmaceutics at Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, India. He has more than 20 years of academic and research experience and has published more than 100 research and review papers, edited three books, and authored 20 book chapters on novel drug delivery. He has also published two Indian patents and has three applications under evaluation. He is a reviewer for three high-impact journals and is on the editorial boards of several scientific journals.

Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India. Previously, she was a research scientist on a project of the Indian Council of Medical Research (ICMR) at King George’s Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. She has authored or edited 14 books and has organized several national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

22.11.2024

Abbildungen

farbige, schwarzweisse Abbildungen

Herausgeber

Verlag

Taylor and Francis

Seitenzahl

398

Maße (L/B/H)

24/16,1/2,7 cm

Gewicht

930 g

Sprache

Englisch

ISBN

978-1-77491-674-2

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Cancer Vaccination and Challenges
  • Produktbild: Cancer Vaccination and Challenges
  • 1. Cancer Vaccines: Types, Mechanisms, and Recent Developments 2. Strategies to Develop Cancer Vaccines 3. Role of Tumor Antigens for Cancer Vaccine Development 4. DNA-Based Cancer Vaccine: Advancements and Challenges 5. RNA-Based Cancer Vaccines: Advancements and Challenges 6. Utilization of Microbial Genes as a Vaccine Against Cancer 7. Utilization of Protein and Peptides as Cancer Vaccines: Advancements and Challenges Assessment of Ethnomedical Plants: Shiwalik Hills, Himachal Pradesh, India 8. Stem Cell-Based Cancer Vaccines as Promising Immuno-therapy: Current Progress and Challenges 9. Preventive Cancer Vaccine 10. Providing Cognitive Platforms for the Effectiveness of Cancer Vaccines 11. Survival Data and Therapeutic Outcomes of Cancer Vaccines 12. Regulatory Considerations for Cancer Vaccines Development